Novoflow key facts
- Developer of an artificial intelligence (AI) platform designed to automate phone calls for medical clinics.
- It has raised $3.6M; the latest was Seed Round ($3.1M) in Nov 2025.
- Notable investors include Y Combinator, Standard Partners, Justin Hamilton, Multifaceted Capital, N1 (Prague) — 7 tracked in total.
- Status: Privately Held (backing).
- ·Watch Novoflow: the Monday email on marks, rounds and moves
Novoflow funding rounds
No funding rounds for Novoflow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Novoflow investors
7 investors are on record for Novoflow, including Y Combinator, Standard Partners, Justin Hamilton and Multifaceted Capital.
About Novoflow
Developer of an artificial intelligence (AI) platform designed to automate phone calls for medical clinics. The company's platform automates front and back office phone workflows for medical practices, sends follow-ups via text and email to ensure patients are prepared and reduce no-shows, automatically calls patients on waiting lists when appointments become available and reduce empty appointment slots, maximizes provider utilization, and saves cost, enabling clinics to effectively manage their appointments over the phone and reduce manual work.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 5
- Website
- novoflow.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Novoflow doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.